Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Cellular component
- GO: Molecular function
- GO: Biological process
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: hoga1 ENSDARG00000018944

.

Description

4-hydroxy-2-oxoglutarate aldolase 1 [Source:ZFIN;Acc:ZDB-GENE-040426-2242]

Gene Synonyms

zgc:77082

Location

Chromosome 22: 34,710,036-34,732,882 forward strand.

GRCz11:CM002906.2

About this gene

This gene has 3 transcripts (splice variants), 179 orthologues and 1 paralogue.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000025820.9	hoga1-201	1581	324aa	ENSDARP00000021126.6	Gene/transcipt that contains an open reading frame (ORF).Protein coding	Q6NY77	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000155906.2	hoga1-203	998	276aa	ENSDARP00000129648.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000154372.2	hoga1-202	817	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-	-

.

Summary

.

.